1. Home
  2. NRP vs AUPH Comparison

NRP vs AUPH Comparison

Compare NRP & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRP
  • AUPH
  • Stock Information
  • Founded
  • NRP 2002
  • AUPH 1993
  • Country
  • NRP United States
  • AUPH Canada
  • Employees
  • NRP N/A
  • AUPH N/A
  • Industry
  • NRP Coal Mining
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRP Energy
  • AUPH Health Care
  • Exchange
  • NRP Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • NRP 1.3B
  • AUPH 1.2B
  • IPO Year
  • NRP N/A
  • AUPH 1999
  • Fundamental
  • Price
  • NRP $102.68
  • AUPH $10.49
  • Analyst Decision
  • NRP
  • AUPH Strong Buy
  • Analyst Count
  • NRP 0
  • AUPH 4
  • Target Price
  • NRP N/A
  • AUPH $12.25
  • AVG Volume (30 Days)
  • NRP 26.4K
  • AUPH 2.3M
  • Earning Date
  • NRP 08-06-2025
  • AUPH 07-31-2025
  • Dividend Yield
  • NRP 2.96%
  • AUPH N/A
  • EPS Growth
  • NRP N/A
  • AUPH N/A
  • EPS
  • NRP 10.41
  • AUPH 0.42
  • Revenue
  • NRP $229,909,000.00
  • AUPH $260,111,000.00
  • Revenue This Year
  • NRP N/A
  • AUPH $12.15
  • Revenue Next Year
  • NRP N/A
  • AUPH $18.34
  • P/E Ratio
  • NRP $9.84
  • AUPH $24.96
  • Revenue Growth
  • NRP N/A
  • AUPH 25.59
  • 52 Week Low
  • NRP $81.74
  • AUPH $5.20
  • 52 Week High
  • NRP $113.04
  • AUPH $10.67
  • Technical
  • Relative Strength Index (RSI)
  • NRP 60.23
  • AUPH 75.29
  • Support Level
  • NRP $100.00
  • AUPH $8.73
  • Resistance Level
  • NRP $106.73
  • AUPH $9.37
  • Average True Range (ATR)
  • NRP 2.79
  • AUPH 0.45
  • MACD
  • NRP 0.35
  • AUPH 0.10
  • Stochastic Oscillator
  • NRP 59.30
  • AUPH 98.48

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. Geographically, the business activity of the group functions through the United States.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: